Psychotic Disorders
Conditions
Brief summary
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with Diagnostic Statistical Manual (DSM-V) schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual (TAU) (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Detailed description
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with DSM-V schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual \[TAU\] (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Interventions
6 weeks of empowerment program and supported face to face discussion
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult aged 16 years or more * Able to read and write in an Arabic * Able to consent * Diagnosed with schizophrenia * Volunteers
Exclusion criteria
* Learning disability * Not able to read or write
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Modified Learned Helplessness | Up to 6 months | Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Empowerment level | Up to 6 months | Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May) |
| Psychiatric symptoms | Up to 6 months | Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May) |
| recovery assessment scale | Up to 6 months | Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May) |
| Quality of life | Up to 6 months | Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May) |